Bloomberg Law   |  April 23, 2021

Read the Publication

The U.S. holds two keys to enabling low- and middle-income countries to make vaccines for themselves: federally funded technology and patents, say Georgetown University’s Matthew Kavanagh and Georgetown Law’s Madhavi Sunder. They call on the Biden administration to push drug companies do more to help with global vaccination to fight Covid-19.

Read more here.

Latest publications See All